The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online October 30, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0901521
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0901521v1
183/10/6500    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jabbour, M.
Right arrow Articles by Lybarger, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jabbour, M.
Right arrow Articles by Lybarger, L.

Discrete Domains of MARCH1 Mediate Its Localization, Functional Interactions, and Posttranscriptional Control of Expression1

Maurice Jabbour,* Erin M. Campbell,{dagger} Hanna Fares,{dagger} and Lonnie Lybarger2*{ddagger}

*Department of Immunobiology, {dagger}Department of Molecular and Cellular Biology, and {ddagger}Department of Cell Biology and Anatomy, University of Arizona, Tucson, AZ 85724

Within APCs, ubiquitination regulates the trafficking of immune modulators such as MHC class II and CD86 (B7.2) molecules. MARCH1 (membrane-associated RING-CH), a newly identified ubiquitin E3 ligase expressed in APCs, ubiquitinates MHC class II, thereby reducing its surface expression. Following LPS-induced maturation of dendritic cells, MARCH1 mRNA is down-regulated and MHC class II is redistributed to the cell surface from endosomal compartments. Here, we show that MARCH1 expression is also regulated at the posttranscriptional level. In primary dendritic cell and APC cell lines of murine origin, MARCH1 had a half-life of <30 min. MARCH1 degradation appears to occur partly in lysosomes, since inhibiting lysosomal activity stabilized MARCH1. Similar stabilization was observed when MARCH1-expressing cells were treated with cysteine protease inhibitors. Mutational analyses of MARCH1 defined discrete domains required for destabilization, proper localization, and functional interaction with substrates. Taken together, these data suggest that MARCH1 expression is regulated at a posttranscriptional level by trafficking within the endolysosomal pathway where MARCH1 is proteolyzed. The short half-life of MARCH1 permits very rapid changes in the levels of the protein in response to changes in the mRNA, resulting in efficient induction of Ag presentation once APCs receive maturational signals.

2 Address correspondence and reprint requests to Dr. Lonnie Lybarger, Department of Cell Biology and Anatomy, University of Arizona, 1501 N. Campbell Avenue, LSN 444, Tucson, AZ 85724. E-mail address: lybarger{at}email.arizona.edu

1 This work was supported by grants from the National Institutes of Health (AI060723) and from the Arizona Biomedical Research Commission (8-123).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.